• Je něco špatně v tomto záznamu ?

Increased intestinal permeability in patients with short bowel syndrome is not affected by parenteral nutrition

A. Cinkajzlová, Z. Lacinová, J. Kloučková, P. Kaválková, H. Kratochvílová, J. Křížová, P. Trachta, M. Mráz, M. Haluzík

. 2019 ; 68 (5) : 817-825. [pub] 20190819

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20005506

Grantová podpora
NV15-27863A MZ0 CEP - Centrální evidence projektů

The aim of our study was to assess the presence and degree of intestinal leakage in subjects suffering from short bowel syndrome (SBS) and its modification by parenteral nutrition. To this end we assessed circulating levels of selected makers of intestinal permeability including zonulin, fatty acid binding protein 2 (FABP-2), citrulline and glucagon-like peptide 2 (GLP-2). We also measured lipopolysaccharide binding protein (LBP) as a marker of circulating levels of lipopolysaccharide acting through the CD14 molecule. Eleven SBS and 10 age- and BMI-matched control subjects were included into the study. The effect of parenteral nutrition was assessed after 14 days, 6 and 12 months from its initiation, respectively. At baseline, SBS patients had increased gut permeability as measured by zonulin (47.24+/-2.14 vs. 39.48+/-1.20 ng/ml, p=0.006) and LBP (30.32+/-13.25 vs. 9.77+/-0.71 microg/ml, p<0.001) compared to healthy controls. Furthermore, SBS subjects had reduced FABP-2, unchanged citrulline and increased sCD14 and GLP-2 relative to control group. Throughout the whole study period the administered parenteral nutrition had no significant effect on any of the studied parameters. Taken together, our data show that patients with short bowel syndrome have increased intestinal permeability that is not affected by parenteral nutrition.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc20005506
003      
CZ-PrNML
005      
20201019163328.0
007      
ta
008      
200511s2019 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.934134 $2 doi
035    __
$a (PubMed)31424246
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Cinkajzlová, Anna $7 xx0228108 $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Increased intestinal permeability in patients with short bowel syndrome is not affected by parenteral nutrition / $c A. Cinkajzlová, Z. Lacinová, J. Kloučková, P. Kaválková, H. Kratochvílová, J. Křížová, P. Trachta, M. Mráz, M. Haluzík
504    __
$a Literatura
520    9_
$a The aim of our study was to assess the presence and degree of intestinal leakage in subjects suffering from short bowel syndrome (SBS) and its modification by parenteral nutrition. To this end we assessed circulating levels of selected makers of intestinal permeability including zonulin, fatty acid binding protein 2 (FABP-2), citrulline and glucagon-like peptide 2 (GLP-2). We also measured lipopolysaccharide binding protein (LBP) as a marker of circulating levels of lipopolysaccharide acting through the CD14 molecule. Eleven SBS and 10 age- and BMI-matched control subjects were included into the study. The effect of parenteral nutrition was assessed after 14 days, 6 and 12 months from its initiation, respectively. At baseline, SBS patients had increased gut permeability as measured by zonulin (47.24+/-2.14 vs. 39.48+/-1.20 ng/ml, p=0.006) and LBP (30.32+/-13.25 vs. 9.77+/-0.71 microg/ml, p<0.001) compared to healthy controls. Furthermore, SBS subjects had reduced FABP-2, unchanged citrulline and increased sCD14 and GLP-2 relative to control group. Throughout the whole study period the administered parenteral nutrition had no significant effect on any of the studied parameters. Taken together, our data show that patients with short bowel syndrome have increased intestinal permeability that is not affected by parenteral nutrition.
650    _2
$a proteiny akutní fáze $7 D000209
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a transportní proteiny $x krev $7 D002352
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a citrulin $x krev $7 D002956
650    _2
$a proteiny vázající mastné kyseliny $x krev $7 D050556
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glukagonu podobný peptid 2 $x krev $7 D053767
650    _2
$a haptoglobiny $7 D006242
650    _2
$a lidé $7 D006801
650    12
$a intestinální absorpce $7 D007408
650    _2
$a tenké střevo $x metabolismus $x patofyziologie $7 D007421
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové glykoproteiny $x krev $7 D008562
650    _2
$a lidé středního věku $7 D008875
650    12
$a parenterální výživa $7 D010288
650    _2
$a permeabilita $7 D010539
650    _2
$a proteinové prekurzory $x krev $7 D011498
650    _2
$a syndrom krátkého střeva $x diagnóza $x krev $x patofyziologie $x terapie $7 D012778
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
700    1_
$a Lacinová, Zdeňka $7 xx0062138
700    1_
$a Kloučková, Jana $7 xx0232313
700    1_
$a Kaválková, Petra $7 xx0094376
700    1_
$a Kratochvílová, Helena, $d 1992- $7 xx0228161
700    1_
$a Křížová, Jarmila $7 xx0017659
700    1_
$a Trachta, Pavel $7 xx0248280
700    1_
$a Mráz, Miloš $7 xx0119173
700    1_
$a Haluzík, Martin, $d 1970- $7 xx0000707
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, č. 5 (2019), s. 817-825
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31424246 $y Pubmed
910    __
$a ABA008 $b A 4120 $c 266 $y p $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20201019163327 $b ABA008
999    __
$a ok $b bmc $g 1528607 $s 1095561
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 68 $c 5 $d 817-825 $e 20190819 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
GRA    __
$a NV15-27863A $p MZ0
LZP    __
$b NLK118 $a Pubmed-20200511

Najít záznam

Citační ukazatele

Možnosti archivace